PARIS (dpa-AFX) - Sanofi and its vaccines global business unit Sanofi Pasteur announced that 500,000 doses of Dengvaxia have been received in Paraná to support a large-scale public dengue immunization program initiated in the State's 30 most highly endemic municipalities.
Paraná State has seen a steep 3-fold increase in both dengue incidence and deaths in recent years. In the last year, there have been 55,000 cases reported, costing the State an estimated R$ 330 million or about 91 million euros in related healthcare expenses.
Sanofi Pasteur will continue to address all supply demands coming from all clinics in Brazil, both public and private, as well as any additional requests from other countries supported by company's ample dengue vaccine supply capacity from its production facility in France.
Copyright RTT News/dpa-AFX
Kostenloser Wertpapierhandel auf Smartbroker.de